首页> 美国卫生研究院文献>Advanced Pharmaceutical Bulletin >Construction and Characterization of Recombinant HEK Cell Over Expressing α4 Integrin
【2h】

Construction and Characterization of Recombinant HEK Cell Over Expressing α4 Integrin

机译:高表达α4整合素的重组HEK细胞的构建与鉴定。

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

>Purpose: Integrins are heterodimeric membrane proteins, which are exposed to post translational modifications in eukaryotic cells in contrast to prokaryotic cells. These modifications provide advantages for production of proper nanobody, mono and polyclonal antibody against this surface protein and also in aptamer selection process. Since the majority of diagnostic and therapeutic antibodies, target the surface epitopes, eukaryotic membrane proteins provide an appropriate model for further investigation on therapeutic agents. >Methods: Escherichia coli strain top 10, was used as host for ITGA-4 expression vector encoding the human integrin α4. The plasmid was extracted and consequently, ITGA-4 vector was digested to make a linear plasmid. Human Embryonic Kidney-293 (HEK-293) cell transfected with linear plasmid and subsequently screened for stable ITGA-4 expressing Cells. Three separated clones were isolated twenty one days after transfection. Chromosomal DNA was extracted from ITGA-4-transfected cells. The presence of ITGA-4 gene in HEK-293 genome was confirmed by PCR. The expression level of ITGA-4 on HEK-293 cells was also analyzed by Flow cytometry. >Results: Flow cytometric analysis showed that HEK-293 cells have no expression of integrin α4 on their surface while 95% of transfected HEK-293 cells with ITGA4, expressed different levels of integrin α4 on their surfaces which correlates well with genomic DNA PCR amplification results. >Conclusion: The results suggest that we have successfully constructed the integrin α4 expressing HEK293 cell, which will facilitate further research into the production of antibody, nanobody and aptamer against α4 integrin.
机译:>目的:整合素是异二聚体膜蛋白,与原核细胞相比,它们在真核细胞中暴露于翻译后修饰。这些修饰为生产针对该表面蛋白的合适的纳米抗体,单克隆抗体和多克隆抗体以及在适体选择过程中提供了优势。由于大多数诊断和治疗抗体均靶向表面表位,因此真核膜蛋白为进一步研究治疗剂提供了合适的模型。 >方法:大肠杆菌前10名菌株被用作编码人整联蛋白α4的ITGA-4表达载体的宿主。提取质粒,然后消化ITGA-4载体以制备线性质粒。用线性质粒转染的人胚肾293(HEK-293)细胞,然后筛选表达ITGA-4的稳定细胞。转染二十一天后,分离出三个分离的克隆。从ITGA-4转染的细胞中提取染色体DNA。通过PCR确认了HEK-293基因组中ITGA-4基因的存在。还通过流式细胞术分析了ITGA-4在HEK-293细胞上的表达水平。 >结果:流式细胞仪分析显示,HEK-293细胞表面无整合素α4表达,而转染HEGA-293细胞的95%的ITGA4表达不同水平的整合素α4。与基因组DNA PCR扩增结果良好。 >结论:结果表明,我们已经成功构建了表达整合素α4的HEK293细胞,这将有助于进一步研究针对α4整合素的抗体,纳米抗体和适体的生产。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号